Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Go back to Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million| Fabien Corp (NASDAQ: FBIO) | Delayed: 3.08 +0.09 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.99 | 52 Week High | $4.66 | |||
| Open | $2.99 | 52 Week Low | $2.01 | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $0.00 | |||
| Volume | 538,155 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 3.08 +0.09 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.99 | 52 Week High | $4.66 | |||
| Open | $2.99 | 52 Week Low | $2.01 | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $0.00 | |||
| Volume | 538,155 | |||||
